List your tool
Contact for Pricing

Berg Health

AI-enabled biotech that mines patient biology for drug targets and biomarkers

3.3 Healthcare AIResearch
3.3 Good 3.3
Tackles a specific problem: finding drug targets and biomarkers from patient biology No self-serve product or public pricing, so evaluation means a sales conversation
Reviewed by Challenging Voice Editorial · Updated Oct 2026 How we rate
PricingContact for Pricing
Free planNo
CompanyBerg
PlatformsWeb
CategoryHealthcare AI
Founded2008
Last reviewedOct 2026

Is this your tool?

  • Claim this listing. Sign in with an email at your domain to manage it. Claim Berg Health
  • Get into the top 5 of Healthcare AI. 5 of 5 spots open, from $159/month. See positions
  • Something out of date? Owners can request edits from My listings; anyone can tell us.
Ask AI about Berg Health ChatGPT Claude Perplexity

Overview

Berg Health is a biotech company that applies AI to patient biology to find drug targets and biomarkers. It isn't a consumer app or a clinic tool. It's built for pharma partners and researchers who want to understand why a disease behaves the way it does, then turn that into therapies and diagnostics.

What Berg Health Does

Berg Health develops drugs and diagnostics by analysing biological samples from patients with AI. The company is based in Massachusetts and has operated since the late 2000s.

Most "health AI" you'll find on this site helps with operations, such as scheduling or documentation. Berg is different. It sits upstream, closer to the lab than the clinic.

How the Interrogative Biology Platform Works

Berg calls its approach Interrogative Biology. The platform collects large sets of biological data from patient-derived samples, then uses machine learning to look for relationships that point to disease drivers.

The aim is to let the data suggest hypotheses instead of starting from a theory and testing it. That's the pitch, and it's a sound one in principle. Whether it beats conventional discovery is something only clinical results can show.

Berg also develops its own drug candidates, mostly in oncology. That matters because the platform is judged on real pipeline outcomes, not on demos.

Who Berg Health Suits

Berg Health suits pharmaceutical teams, academic groups and investors who want an AI partner for target discovery or biomarker work. If your question is "which molecular signals separate responders from non-responders?", this is the right kind of company to talk to.

It doesn't suit a hospital looking for workflow automation. For that, look at tools like Health Catalyst, which focuses on healthcare data and analytics for providers.

Where Berg Health Doesn't Fit

Berg doesn't offer a sign-up page, a free tier or a public price list. Evaluating it means a conversation, and likely a scoped collaboration.

Drug discovery is also slow. Expect years, not weeks, between a platform insight and a validated therapy. And independent verification of the platform's claims is limited, so treat company statements as claims until trial data backs them.

If you're after personal health tracking instead, our guide to AI health monitoring devices and wearables covers a more practical starting point. Berg's pricing, features and alternatives sit in the sections above and below this profile.

Key features

  • Interrogative Biology platform that combines patient-derived biological data with AI analysis
  • Bayesian-style machine learning used to infer causal links in disease biology
  • Biomarker discovery to support diagnostics and patient stratification
  • Drug target identification across oncology and other disease areas
  • In-house clinical-stage drug development programs

Screenshots & demo

Demo video

Screenshots

Berg Health screenshot 1Berg Health screenshot 2

Pricing

Berg Health uses custom pricing. Contact their team for a quote based on your needs.

  • Pricing modelContact for Pricing
  • Starting priceCustom
  • Free planNo
Visit Berg Health

Pricing is provided as a guide. Check the official site for the latest plans.

Pros & cons

Pros

  • Tackles a specific problem: finding drug targets and biomarkers from patient biology
  • Uses human-derived data rather than relying only on animal or cell models
  • Runs its own clinical programs, so the platform is tested against real drug development
  • Suited to pharma and research partners rather than generic analytics buyers

Cons

  • No self-serve product or public pricing, so evaluation means a sales conversation
  • Aimed at biotech and pharma, not individual patients or clinics
  • Drug development outcomes are slow and uncertain, and platform claims are hard to verify independently
  • Limited public technical documentation compared with developer-focused AI tools

Frequently asked questions

What is Berg Health?
Berg Health is a biotech company that applies AI to patient biology to find drug targets and biomarkers.
Is Berg Health free?
Berg Health does not offer a free plan.

Reviews

3.3 Editorial rating No reviews yet

Write a review